A146 ASSESSMENT OF THE USE OF THERAPEUTIC DRUG MONITORING OF INFLIXIMAB DURING MAINTENANCE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE

BACKGROUND: Infliximab (IFX) was proven effective in the induction and maintenance of remission in inflammatory bowel diseases (IBD) in both children and adults. There is a significant number of individual who lose response to the medication. Measurable IFX drug levels correlate with clinical respon...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Can Assoc Gastroenterol
Main Authors: Chavannes, M, Gervais, F, Robitaille, R, Marchand, V, Deslandres, C, Jantchou, P
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Poster Presentations
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507680/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.147
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki